ArticleClinical immunology (Orlando, Fla.)2022

Combined administration of inhaled DNase, baricitinib and tocilizumab as rescue treatment in COVID-19 patients with severe respiratory failure.

Efstratios Gavriilidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.